Use of mood-stabilizing drug linked with reduced risk of developing head and neck cancer

A new study indicates that a commonly used mood stabilizing drug may help prevent head and neck cancer. Valproic acid (VPA) is currently prescribed as an anti-seizure medication and mood stabilizer, but it is also being studied as an anticancer agent